Vitelliform Macular Dystrophy 4 C4015342
A genetic eye condition affecting the macula, causing fatty deposits that impair central vision. It follows an autosomal dominant inheritance pattern. Treatment focuses on monitoring and supportive visual aids.
Key facts at a glance
- ICD-10
- Q15.9
- ICD-11
- LA00.0
- Body system
- ophthalmologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Decreased central visual acuity
Sudden vision loss due to choroidal neovascularization
Generalized symptoms
(ophthalmologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Metamorphopsia (distorted vision)
(ophthalmologic)Yellowish vitelliform lesion on fundus
(ophthalmologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Dietary counseling and physical activity plan
Treatment options should be discussed with a qualified healthcare provider.
Regular ophthalmologic monitoring
Scheduled comprehensive eye examinations including visual acuity testing, funduscopy, and OCT imaging to track disease progression and identify complications such as choroidal neovascularization.
Anti-VEGF intravitreal therapy
Intravitreal injections of anti-vascular endothelial growth factor agents to manage secondary choroidal neovascularization complications that may develop in vitelliform lesions.
Additional treatment options
Low vision rehabilitation services
Utilization of magnifying devices, specialized lighting, and adaptive technologies to maximize functional vision and maintain independence in daily activities.
lifestyleVitrectomy for vitreous opacities
Surgical removal of vitreous opacities or epiretinal membranes that may develop secondary to vitelliform lesions and impair visual function.
surgicalVision loss counseling and support
Psychological support services including counseling and peer support groups to address anxiety, depression, and adjustment challenges associated with progressive vision loss.
psychologicalMedication Comparisons
Compare medications used to treat Vitelliform Macular Dystrophy 4 C4015342. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy